rs774271810
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 5P and 2B. PM1PM2PP2BP4_Moderate
The NM_005677.4(COLQ):c.164C>T(p.Thr55Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T55A) has been classified as Uncertain significance.
Frequency
Consequence
NM_005677.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COLQ | NM_005677.4 | c.164C>T | p.Thr55Met | missense_variant | Exon 2 of 17 | ENST00000383788.10 | NP_005668.2 | |
| COLQ | NM_080538.2 | c.134C>T | p.Thr45Met | missense_variant | Exon 2 of 17 | NP_536799.1 | ||
| COLQ | NM_080539.4 | c.164C>T | p.Thr55Met | missense_variant | Exon 2 of 16 | NP_536800.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COLQ | ENST00000383788.10 | c.164C>T | p.Thr55Met | missense_variant | Exon 2 of 17 | 1 | NM_005677.4 | ENSP00000373298.3 | ||
| COLQ | ENST00000603808.5 | c.164C>T | p.Thr55Met | missense_variant | Exon 2 of 17 | 1 | ENSP00000474271.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251418 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.0000316 AC XY: 23AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 5 Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 55 of the COLQ protein (p.Thr55Met). This variant is present in population databases (rs774271810, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with COLQ-related conditions. ClinVar contains an entry for this variant (Variation ID: 536240). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.164C>T (p.T55M) alteration is located in exon 2 (coding exon 2) of the COLQ gene. This alteration results from a C to T substitution at nucleotide position 164, causing the threonine (T) at amino acid position 55 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at